跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-TELMISARTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-TELMISARTAN
Authorized
STANDARD
MINT-TELMISARTAN
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
99884af6a21eea51
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
99884af6a21eea51
Drug Approval Canada Name
MINT-TELMISARTAN
Product Name
MINT-TELMISARTAN
Status
Marketed
Status Date
2020-03-18
Original Market Date
2020-03-18
Din
02486377
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09CA07 TELMISARTAN
Atc Name
c 09 ca 07
Aig Number
0138223002
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
TELMISARTAN
80 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
99884af6a21eea51
Type
Standard
Back to Health Canada Approvals